As India experiences its deadliest coronavirus surge yet, there is growing pressure on the World Trade Organization to temporarily waive intellectual property rights for COVID-19 vaccines. That would allow other countries to produce the vaccine and distribute more to less-wealthy countries. The US has not supported the idea, but now the White House says US Trade Representative Katherine Tai will hold talks with the WTO on how to adjust license and manufacturing issues to get the COVID-19 vaccine more widely distributed and shared. Marco Werman speaks with Thiru Balasubramaniam, Geneva Representative of Knowledge Ecology International (KEI), a nongovernmental organization that focuses on the effects of intellectual property on public health, cyberlaw and e-commerce.
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!